Zurück
  • Poster
  • P-1-42

Improved clinical outcome of Covid-19 in haematologic malignancy patients receiving a fourth dose of anti-SARS-Cov-2 vaccine: an epicovideha report

Termin

Datum:
Zeit:
Redezeit:
Diskussionszeit:
Ort / Stream:
Foyer

Session

Postersession I

Thema

  • Immune Prevention and Therapy

Mitwirkende

Dr. Jon Salmanton-García (Cologne/ DE), Francesco Marchesi (Rome/ IT), Andreas Glenthøj (Copenhagen/ DK), Yavuz M. Bilgin (Goes/ NL), Jens Van Praet (Brugge/ BE), Laman Rahimli (Cologne/ DE), Prof. Oliver A. Cornely (Cologne/ DE), Livio Pagano (Rome/ IT)

  • © Conventus Congressmanagement & Marketing GmbH